{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:52:45Z","timestamp":1790567565561,"version":"4.1.0"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n A wide range of medications, noncombustible nicotine products, behavioral support, and alternative treatments are available in England to help people stop smoking. Understanding their effectiveness outside of clinical trial settings can support informed decision-making.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To provide up-to-date estimates of the prevalence of different smoking cessation aids and associations with quit success and to explore moderation by socioeconomic position.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This survey study used data from the Smoking Toolkit Study, a monthly cross-sectional household survey, conducted from 2006 to 2024 in England, UK. Participants were individuals aged at least 16 years who reported trying to quit smoking in the past year. Analyses were conducted from July to November 2024.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n \n The outcome variable was self-reported success in quitting smoking from the start of the most recent quit attempt up to the time of survey (hereafter,\n quit success<\/jats:italic>\n ). Independent variables were use (yes or no) of the following aids in the most recent attempt: nicotine replacement therapy (NRT), obtained via prescription or over-the-counter; varenicline; bupropion; electronic cigarettes (e-cigarettes); face-to-face behavioral support; telephone support; written self-help materials; websites; smartphone apps; hypnotherapy; Allen Carr\u2019s Easyway method; heated tobacco products (HTPs); and nicotine pouches. Covariates included sociodemographic characteristics and features of the quit attempt.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 25\u202f094 participants (mean [SD] age, 38.7 [15.3] years; 51.5% [95% CI, 50.8%-52.2%] men) were included. In 2023 to 2024, the most used aids were e-cigarettes (40.2% [95% CI, 37.6%-42.8%]) and over-the-counter NRT (17.3% [95% CI, 15.3%-19.2%]); 40.8% (95% CI, 38.2%-43.4%) of quit attempts were unaided. While e-cigarette use was associated with higher odds of quit success after adjustment for use of other aids and covariates (odds ratio [OR], 1.95 [95% CI, 1.74-2.17]), use of over-the-counter NRT was not (OR, 1.03 [95% CI, 0.93-1.15]). Other aids positively associated with quit success were websites (used by 4.6% [95% CI, 3.5%-5.7%] in 2023-2024; OR, 1.43 [95% CI, 1.03-1.98]), prescription NRT (used by 4.5% [95% CI, 3.4%-5.5%] in 2023-2024; OR, 1.33 [95% CI, 1.12-1.58]), varenicline (used by 1.1% [95% CI, 0.5%-1.7%] in 2023-2024; OR, 1.80 [95% CI, 1.50-2.18]), and HTPs (used by 0.7% [95% CI, 0.3%-1.1%] in 2023-2024; OR, 2.37 [95% CI, 1.24-4.51]). Face-to-face behavioral support (used by 2.2% [95% CI, 1.5-2.9] in 2023-2024) was associated with higher odds of quit success among those from less advantaged (OR, 1.59 [95% CI, 1.19-2.14]) but not more advantaged (OR, 0.91 [95% CI, 0.65-1.29]) socioeconomic positions. There was not clear evidence of a benefit of any other aid, although some analyses were inconclusive.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This cross-sectional study found that while a range of effective smoking cessation aids are available in England, many people tried to quit using less effective forms of support or none at all. Quit success rates could be improved by encouraging people to use more effective methods.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.54962","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T11:31:19Z","timestamp":1737113479000},"page":"e2454962","source":"Crossref","is-referenced-by-count":39,"title":["Prevalence of Popular Smoking Cessation Aids in England and Associations With Quit Success"],"prefix":"10.1001","volume":"8","author":[{"given":"Sarah E.","family":"Jackson","sequence":"first","affiliation":[{"name":"Department of Behavioural Science and Health, University College London, London, United Kingdom"},{"name":"SPECTRUM Consortium, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Behavioural Science and Health, University College London, London, United Kingdom"},{"name":"SPECTRUM Consortium, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Buss","sequence":"additional","affiliation":[{"name":"Department of Behavioural Science and Health, University College London, London, United Kingdom"},{"name":"SPECTRUM Consortium, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lion","family":"Shahab","sequence":"additional","affiliation":[{"name":"Department of Behavioural Science and Health, University College London, London, United Kingdom"},{"name":"SPECTRUM Consortium, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"issue":"8","key":"zoi241547r1","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1080\/08870446.2017.1325890","article-title":"Tobacco smoking: health impact, prevalence, correlates and interventions.","volume":"32","author":"West","year":"2017","journal-title":"Psychol Health"},{"issue":"1","key":"zoi241547r2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1360-0443.2004.00540.x","article-title":"Shape of the relapse curve and long-term abstinence among untreated smokers.","volume":"99","author":"Hughes","year":"2004","journal-title":"Addiction"},{"key":"zoi241547r3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1749-6632.2011.06202.x","article-title":"Socioeconomic status and smoking: a review.","volume":"1248","author":"Hiscock","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"zoi241547r4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000146.pub5","article-title":"Nicotine replacement therapy versus control for smoking cessation.","volume":"5","author":"Hartmann-Boyce","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"zoi241547r5","article-title":"Electronic cigarettes for smoking cessation.","volume":"1","author":"Lindson","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"zoi241547r6","article-title":"Behavioural interventions for smoking cessation: an overview and network meta-analysis.","volume":"1","author":"Hartmann-Boyce","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"zoi241547r7","article-title":"Nicotine receptor partial agonists for smoking cessation.","volume":"5","author":"Livingstone-Banks","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"zoi241547r8","article-title":"Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses.","volume":"9","author":"Lindson","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"7689","key":"zoi241547r9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/d41586-018-01023-3","article-title":"Robust research needs many lines of evidence.","volume":"553","author":"Munaf\u00f2","year":"2018","journal-title":"Nature"},{"key":"zoi241547r10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/1471-2458-11-479","article-title":"\u2018The smoking toolkit study\u2019: a national study of smoking and smoking cessation in England.","volume":"11","author":"Fidler","year":"2011","journal-title":"BMC Public Health"},{"issue":"9","key":"zoi241547r11","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1111\/add.14656","article-title":"Moderators of real-world effectiveness of smoking cessation aids: a population study.","volume":"114","author":"Jackson","year":"2019","journal-title":"Addiction"},{"issue":"9","key":"zoi241547r12","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1111\/add.15903","article-title":"Prevalence of use and real-world effectiveness of smoking cessation aids during the COVID-19 pandemic: a representative study of smokers in England.","volume":"117","author":"Jackson","year":"2022","journal-title":"Addiction"},{"issue":"9","key":"zoi241547r13","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1111\/add.12623","article-title":"Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study.","volume":"109","author":"Brown","year":"2014","journal-title":"Addiction"},{"issue":"3","key":"zoi241547r14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/add.12429","article-title":"\u2018Real-world\u2019 effectiveness of smoking cessation treatments: a population study.","volume":"109","author":"Kotz","year":"2014","journal-title":"Addiction"},{"key":"zoi241547r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2022.107442","article-title":"Real-world effectiveness of smoking cessation aids: a population survey in England with 12-month follow-up, 2015-2020.","volume":"135","author":"Jackson","year":"2022","journal-title":"Addict Behav"},{"issue":"10","key":"zoi241547r16","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.mayocp.2014.07.004","article-title":"Prospective cohort study of the effectiveness of smoking cessation treatments used in the \u201creal world.\u201d","volume":"89","author":"Kotz","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"zoi241547r20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/14550725241270227","article-title":"A taste of Nordic freedom: The problematic marketing of nicotine pouches in the United Kingdom.","volume":"41","author":"O\u2019Hagan","year":"2024","journal-title":"Nordisk Alkohol Nark"},{"issue":"3","key":"zoi241547r23","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1360-0443.2010.03226.x","article-title":"Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerstr\u00f6m Test for Nicotine Dependence and its components.","volume":"106","author":"Fidler","year":"2011","journal-title":"Addiction"},{"key":"zoi241547r25","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3389\/fpsyg.2014.00781","article-title":"Using Bayes to get the most out of non-significant results.","volume":"5","author":"Dienes","year":"2014","journal-title":"Front Psychol"},{"issue":"3","key":"zoi241547r27","article-title":"Individual behavioural counselling for smoking cessation.","volume":"3","author":"Lancaster","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"zoi241547r28","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMoa2308815","article-title":"Electronic nicotine-delivery systems for smoking cessation.","volume":"390","author":"Auer","year":"2024","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi241547r30","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/ntr\/ntr297","article-title":"The use of nicotine replacement therapy for smoking reduction and temporary abstinence: an interview study.","volume":"14","author":"Beard","year":"2012","journal-title":"Nicotine Tob Res"},{"issue":"5","key":"zoi241547r31","first-page":"305","article-title":"Optimising nicotine replacement therapy in clinical practice.","volume":"42","author":"Mendelsohn","year":"2013","journal-title":"Aust Fam Physician"},{"issue":"6","key":"zoi241547r32","article-title":"Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.","volume":"6","author":"Theodoulou","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"zoi241547r33","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/add.16485","article-title":"Impact of the disruption in supply of varenicline since 2021 on smoking cessation in England: A population study.","volume":"119","author":"Jackson","year":"2024","journal-title":"Addiction"},{"key":"zoi241547r36","doi-asserted-by":"publisher","DOI":"10.2196\/43242","article-title":"The effectiveness of smartphone app-based interventions for assisting smoking cessation: systematic review and meta-analysis.","volume":"25","author":"Guo","year":"2023","journal-title":"J Med Internet Res"},{"issue":"10","key":"zoi241547r37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006611.pub5","article-title":"Mobile phone text messaging and app-based interventions for smoking cessation.","volume":"10","author":"Whittaker","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"zoi241547r38","doi-asserted-by":"publisher","DOI":"10.2196\/45111","article-title":"Effectiveness of eHealth smoking cessation interventions: systematic review and meta-analysis.","volume":"25","author":"Fang","year":"2023","journal-title":"J Med Internet Res"},{"key":"zoi241547r39","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.12688\/f1000research.16148.1","article-title":"Relative effectiveness of a full versus reduced version of the \u2018Smoke Free\u2019 mobile application for smoking cessation: an exploratory randomised controlled trial.","volume":"7","author":"Crane","year":"2018","journal-title":"F1000Res"},{"issue":"4","key":"zoi241547r40","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/ntr\/ntab198","article-title":"The new nicotine pouch category: a tobacco harm reduction tool?","volume":"24","author":"Patwardhan","year":"2022","journal-title":"Nicotine Tob Res"},{"issue":"5","key":"zoi241547r41","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/add.14897","article-title":"Comparison of Allen Carr\u2019s Easyway programme with a specialist behavioural and pharmacological smoking cessation support service: a randomized controlled trial.","volume":"115","author":"Frings","year":"2020","journal-title":"Addiction"},{"issue":"4","key":"zoi241547r42","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/tobaccocontrol-2018-054243","article-title":"Allen Carr\u2019s Easyway to stop smoking\u2014a randomised clinical trial.","volume":"28","author":"Keogan","year":"2019","journal-title":"Tob Control"},{"issue":"5","key":"zoi241547r43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002850.pub4","article-title":"Telephone counselling for smoking cessation.","volume":"5","author":"Matkin","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"zoi241547r44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000031.pub6","article-title":"Antidepressants for smoking cessation.","volume":"5","author":"Hajizadeh","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"zoi241547r45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001118.pub4","article-title":"Print-based self-help interventions for smoking cessation.","volume":"1","author":"Livingstone-Banks","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"zoi241547r26","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198503682.001.0001","volume-title":"The Theory of Probability","author":"Jeffreys","year":"1998"},{"key":"zoi241547r17","unstructured":"Real-world effectiveness of popular smoking cessation aids in England: an update. Accessed December 5, 2024. https:\/\/osf.io\/uyw5k\/"},{"key":"zoi241547r18","doi-asserted-by":"crossref","unstructured":"Kock? L, Tattan-Birch? H, Jackson? S, Shahab? L, Brown? J. Socio-demographic, smoking and drinking characteristics in GB: A comparison of independent telephone and face-to-face Smoking and Alcohol Toolkit surveys conducted in March 2022. Qeios. Preprint posted online August 16, 2022. doi:10.32388\/CLXK4D","DOI":"10.32388\/CLXK4D"},{"key":"zoi241547r19","unstructured":"O\u2019Connell? D. Philip Morris could stop making conventional cigarettes. BBC News. November 30, 2016. Accessed November 5, 2024. https:\/\/www.bbc.com\/news\/business-38152297"},{"key":"zoi241547r21","unstructured":"Swedish Match. Annual report 2019. Accessed November 5, 2024. https:\/\/www.swedishmatch.com\/globalassets\/reports\/annual-reports\/2019_swedishmatchannualreport_interactive_en.pdf"},{"key":"zoi241547r22","unstructured":"National Readership Survey. Social grade. Accessed February 3, 2019. https:\/\/www.nrs.co.uk\/nrs-print\/lifestyle-and-classification-data\/social-grade\/"},{"key":"zoi241547r24","unstructured":"Tattan-Birch? H. BayesFactor.info. Accessed May 28, 2024. https:\/\/harry-tattan-birch.shinyapps.io\/bayes-factor-calculator\/"},{"key":"zoi241547r29","unstructured":"NHS Better Health. Vaping to quit smoking. Accessed July 12, 2024. https:\/\/www.nhs.uk\/better-health\/quit-smoking\/vaping-to-quit-smoking\/"},{"key":"zoi241547r34","unstructured":"Action on Smoking and Health, Cancer Research UK. Stepping up: the response of stop smoking services in England to the COVID-19 pandemic. Accessed May 5, 2021. https:\/\/ash.org.uk\/uploads\/ASH-CRUK-Stepping-Up-FINAL.pdf"},{"key":"zoi241547r35","unstructured":"Healthwatch. GP access during COVID-19: a review of our evidence: April 2019\u2013December 2020. 2021. Accessed May 5, 2021. https:\/\/www.healthwatch.co.uk\/sites\/healthwatch.co.uk\/files\/20210215%20GP%20access%20during%20COVID19%20report%20final_0.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2829358\/jackson_2025_oi_241547_1736459203.70328.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T11:31:25Z","timestamp":1737113485000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2829358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.54962","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]}}}